Drug Discovery
AI
Markets
Eli Lilly’s $2.75 Billion Insilico Deal Marks Enterprise AI’s Shift From Hype to Production
Big Pharma's largest generative AI partnership validates vertical specialization over generalist models—and signals that geopolitics won't block deals where ROI is measurable.
Knowledge Base
Technology
What Is Quantum Computing and Why Nations Are Racing to Control It
As French startup Pasqal targets a $2 billion SPAC listing, the global race to achieve quantum advantage intensifies across competing hardware platforms and trillion-dollar applications.